At present, the treatment of children's tics is mainly based on medical treatment. The purpose of this article is to solve some problems in the treatment of children with tics, and discuss the specific clinical effects of medications for children with tics. This article takes 30 children with tics treated in our hospital as the research object, children were randomly divided into two groups, which were treated with Chinese medicine and Western medicine respectively, and the clinical effects of children with tics under different drug treatments were analyzed using statistical methods. The results of the study show that the comprehensive treatment of children with tic syndrome has a good therapeutic effect, the clinical treatment effective rate is 90%, the children's motor tics symptoms are reduced by 45%, the vocal tics symptoms are reduced by 39%, and the adverse reactions are very small. It proves that the effectiveness of drugs in treating children's tic disorder is of great significance for improving the quality of life and learning of sick children.

Villa Ada. Clinical Study on Drug Treatment of Children with Tics. International Journal of Public Health and Preventive Medicine (2021), Vol. 2, Issue 3: 1-12. https://doi.org/10.38007/IJPHPM.2021.020301.

[1] Howland, Robert H. (2016). “Use of Atypical Antipsychotics in Children and Adolescents”, Journal of Psychosocial Nursing & Mental Health Services, 43(8), 15-18. DOI: 10.3928/02793695-20050801-06

[2] Zhu Y, Li Y G, Wang J B. (2015). “Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China”, Gut and Liver, 9(4), 525-533. DOI: 10.5009/gnl14184

[3] Kaur N, Kumar P, Jamwal S. (2016). “Tetrabenazine: Spotlight on Drug Review”, Annals of Neurosciences, 23(3), 176-185.

[4] Yang Bin. (2015). “The Use of the Deep Circumflex Iliac Vessel Pedicle Bone Grafting for the Treatment of Aspetic Necrosis of the Femoral Head in Young and Middle Aged Patients”, Clinical Genetics, 26(26), pp.39-43.

[5] Sciutto, M. J. (2015). “ADHD Knowledge, Misconceptions, and Treatment Acceptability”, Journal of Attention Disorders, 19(2), 91-98. DOI: 10.1177/1087054713493316

[6] Párraga-Martínez, Ignacio, López-Torres-Hidalgo, Jesús D, del Campo-del Campo, José M. (2015). “Long-Term Effects of Plant Stanols on the Lipid Profile of Patients with Hypercholesterolemia. A Randomized Clinical Trial”, Revista Espaola De Cardiología, 68(8), 665-671. DOI: 10.1016/j.rec.2014.07.035

[7] Tamura H, Miyauchi K, Dohi T. (2016). “Comparison of Clinical and Angiographic Outcomes After Bare Metal Stents and Drug-Eluting Stents Following Rotational Atherectomy”, International Heart Journal, 57(2), 150-157. DOI: 10.1536/ihj.15-222

[8] Gerardi M C, Atzeni F, Batticciotto A. (2016). “The Safety of Pregabalin in the Treatment of Fibromyalgia”, Expert Opinion on Drug Safety, 15(11), 1541-1548. DOI: 10.1080/14740338.2016.1242575

[9] Gomberg-Maitland M, Schilz R, Mediratta A. (2015). “Phase I Safety Study of Ranolazine in Pulmonary Arterial Hypertension”, Pulmonary Circulation, 5(4), 691-700. DOI: 10.1086/683813

[10] Gopinathannair R, Etheridge SP, Marchlinski FE. (2015). “Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management”, Journal of the American College of Cardiology, 66(15), 1714-1728. DOI: 10.1016/j.jacc.2015.08.038

[11] Heinrich A K, Lucas H, Schindler L. (2016). “Improved Tumor-Specific Drug Accumulation by Polymer Therapeutics with pH-Sensitive Drug Release Overcomes Chemotherapy Resistance”, Molecular Cancer Therapeutics, 15(5), 998-1007. DOI: 10.1158/1535-7163.mct- 15-0824

[12] Staecker H, Maxwell K S, Morris J R. (2015). “Selecting Appropriate Dose Regimens for AM-101 in the Intratympanic Treatment of Acute Inner Ear Tinnitus”, Audiology & Neurotology, 20(3), 172-182. DOI: 10.1159/000369608